Cusabio recombinant antibodies

Recombinant antibodies (rAbs) are a type of monoclonal antibodies that are generated in vitro from a synthetic gene without immunizing any animals or cultivating any hybridomas. Since the advent of biopanning by phage display, recombinant antibodies have become invaluable reagents. To date, recombinant antibodies are being used in a broad range applications from basic research to drug development of diseases, including COVID-19, cancer, autoimmune disorders, and a host of others.

To fully serve your research with recombinant antibodies, Cusabio has developed 600+ recombinant antibodies. In addition to its own competitive advantages, Cusabio boasts the optimal system for the production of recombinant proteins with superior purity, stronger affinity, and greater consistency from batch to batch.

Why choose Cusabio?

• Advanced phage display technology: Cusabio has been specialized in applying advanced phage display technologies for a wide range of service projects, especially development of recombinant antibody.

• Various types of recombinant antibody: Cusabio offers various types of recombinant antibody, including full-length antibodies, scFv, Fab, sdAb, isotype/subtype and various forms of Fc fusion proteins.

• Rich application types: Cusabio’s recombinant antibodies have been validated on multiple platforms, including WB, IF, IHC, FC, IP, ELISA, GICA and Neutralising.
• High consistency from batch to batch
• Continuity of supply

Recombinant antibodies

Citations

• S Antibody referenced in “A magneto-optical biochip for rapid assay based on the Cotton–Mouton effect of γ-Fe2O3@ Au core/shell nanoparticles”, Journal of nanobiotechnology, 2021.
• SARS-CoV-2 Spike RBD Nanobody referenced in “Potent antiviral activity of Agrimonia pilosa, Galla rhois, and their components against SARS-CoV-2”, Bioorganic & Medicinal Chemistry, 2021.
• HIF1A Antibody, CASP3 Antibody referenced in “PESV represses non-small cell lung cancer cell malignancy through circ_0016760 under hypoxia”, Cancer cell international, 2021.
• Phospho-ERN1 (S724) Antibody referenced in “The ER stress sensor inositol-requiring enzyme 1α in Kupffer cells promotes hepatic ischemia-reperfusion injury”, Journal of Biological Chemistry, 2021.
• CDK4 Antibody and CDK6 Antibody referenced in “Histone Deacetylase Inhibitor-Induced CDKN2B and CDKN2D Contribute to G2/M Cell Cycle Arrest Incurred by Oxidative Stress in Hepatocellular Carcinoma Cells Via Forkhead Box M1 Suppression”, Journal of Cancer, 2021.
• BIRC5 Antibody referenced in “LTBP4 Inhibits the Proliferation and Metastasis in Melanoma by Activating Hippo-YAP Signaling”, Research Square, 2020.